Analysis of epitopic residues introduced into the hybrid peptide vaccines prepared according to the cassette theory
- PMID: 7526571
- DOI: 10.1016/0264-410x(94)90285-2
Analysis of epitopic residues introduced into the hybrid peptide vaccines prepared according to the cassette theory
Abstract
In our previous study, we prepared a synthetic peptide vaccine (46F/HA127-133/54A) against influenza strain A/Aichi/2/68 (H3N2) virus by introducing haemagglutinin (HA) 127-133 to an I-Ab,b binding component that consisted of residues 43-46 and 54-58 of an I-Ab,d binding peptide, 46F50V54A. This hybrid peptide vaccine induced considerable immunological responses against A/Aichi/2/68 as well as against the peptide vaccine in I-Ab mice. In the present study, we have attempted to increase the immunogenicity of the peptide vaccine by introducing HA peptides of various lengths into the I-Ab,d binding components consisting of residues 43-46 and 54-58 or 43-47 and 53-58 of 46F50V54A. We demonstrate here that, among the peptide vaccines prepared, 46F/HA127-133/54A (18 mer) consisting of HA127-133 and the I-Ab,d binding component constructed from 43-47 and 53-58 of 46F50V54A induces the most vigorous T-cell responses and neutralizing antibodies against A/Aichi/2/68 in both I-Ab and I-Ad mice.
Similar articles
-
A potential peptide vaccine against two different strains of influenza virus isolated at intervals of about 10 years.Proc Natl Acad Sci U S A. 1994 Sep 27;91(20):9588-92. doi: 10.1073/pnas.91.20.9588. Proc Natl Acad Sci U S A. 1994. PMID: 7937811 Free PMC article.
-
[Development of synthetic peptide vaccine against influenza--T cell epitope the hemagglutinin of A/Aichi/2/68(H3N2) influenza virus induced immune response in mice].Hokkaido Igaku Zasshi. 1994 Jul;69(4):811-20. Hokkaido Igaku Zasshi. 1994. PMID: 7525436 Japanese.
-
Prevention of infection of influenza virus in DQ6 mice, a human model, by a peptide vaccine prepared according to the cassette theory.Vaccine. 1999 Mar 5;17(9-10):1161-8. doi: 10.1016/s0264-410x(98)00336-3. Vaccine. 1999. PMID: 10195628
-
Synthetic recombinant vaccines against viral agents.Int Arch Allergy Immunol. 1995 Dec;108(4):321-6. doi: 10.1159/000237175. Int Arch Allergy Immunol. 1995. PMID: 7580302 Review.
-
Novel Platforms for the Development of a Universal Influenza Vaccine.Front Immunol. 2018 Mar 23;9:600. doi: 10.3389/fimmu.2018.00600. eCollection 2018. Front Immunol. 2018. PMID: 29628926 Free PMC article. Review.
Cited by
-
Recombinant protein comprising multi-neutralizing epitopes induced high titer of antibodies against influenza A virus.Immunobiology. 2003;207(5):305-13. doi: 10.1078/0171-2985-00244. Immunobiology. 2003. PMID: 14575146 Free PMC article.
-
A potential peptide vaccine against two different strains of influenza virus isolated at intervals of about 10 years.Proc Natl Acad Sci U S A. 1994 Sep 27;91(20):9588-92. doi: 10.1073/pnas.91.20.9588. Proc Natl Acad Sci U S A. 1994. PMID: 7937811 Free PMC article.
-
Malaria vaccine candidate: design of a multivalent subunit α-helical coiled coil poly-epitope.Vaccine. 2011 Sep 16;29(40):7090-9. doi: 10.1016/j.vaccine.2011.06.122. Epub 2011 Jul 29. Vaccine. 2011. PMID: 21803099 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Miscellaneous